| Majid Mani, MD | |
|
835 Third Ave, Suite A, Chula Vista, CA 91911-1352 | |
| (619) 425-7755 | |
| (619) 425-9057 |
| Full Name | Majid Mani |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 835 Third Ave, Chula Vista, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043261373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A60640 (California) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | A60640 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pioneers Memorial Healthcare District | 4082527593 | 30 |
| California Retina Associates, Lp | 4284676966 | 16 |
| El Centro Regional Medical Center | 6901986397 | 30 |
News Archive
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
It's not just our DNA that makes us susceptible to disease and influences its impact and outcome. Scientists are beginning to realize more and more that important changes in genes that are unrelated to changes in the DNA sequence itself - a field of study known as epigenetics - are equally influential.
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) colonizes our nasal passages. The study, published today in the Open Access journal PLOS Pathogens, shows for the first time that a protein located on the bacterial surface called clumping factor B (ClfB) has high affinity for the skin protein loricrin.
The Arizona Hospital and Healthcare Association has dropped a lawsuit challenging payment cuts from the state's Medicaid program. The hospital group in November sued the Arizona Health Care Cost Containment System to reverse a 5 percent cut in hospital payment rates.
› Verified 6 days ago
| Entity Name | California Retina Associates, Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114033404 PECOS PAC ID: 4284676966 Enrollment ID: O20050523001307 |
News Archive
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
It's not just our DNA that makes us susceptible to disease and influences its impact and outcome. Scientists are beginning to realize more and more that important changes in genes that are unrelated to changes in the DNA sequence itself - a field of study known as epigenetics - are equally influential.
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) colonizes our nasal passages. The study, published today in the Open Access journal PLOS Pathogens, shows for the first time that a protein located on the bacterial surface called clumping factor B (ClfB) has high affinity for the skin protein loricrin.
The Arizona Hospital and Healthcare Association has dropped a lawsuit challenging payment cuts from the state's Medicaid program. The hospital group in November sued the Arizona Health Care Cost Containment System to reverse a 5 percent cut in hospital payment rates.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Majid Mani, MD 835 Third Ave, Suite A, Chula Vista, CA 91911-1352 Ph: (619) 425-7755 | Majid Mani, MD 835 Third Ave, Suite A, Chula Vista, CA 91911-1352 Ph: (619) 425-7755 |
News Archive
A new technology in the Neonatal Intensive Care Unit at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
It's not just our DNA that makes us susceptible to disease and influences its impact and outcome. Scientists are beginning to realize more and more that important changes in genes that are unrelated to changes in the DNA sequence itself - a field of study known as epigenetics - are equally influential.
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) colonizes our nasal passages. The study, published today in the Open Access journal PLOS Pathogens, shows for the first time that a protein located on the bacterial surface called clumping factor B (ClfB) has high affinity for the skin protein loricrin.
The Arizona Hospital and Healthcare Association has dropped a lawsuit challenging payment cuts from the state's Medicaid program. The hospital group in November sued the Arizona Health Care Cost Containment System to reverse a 5 percent cut in hospital payment rates.
› Verified 6 days ago
Dr. Duane M Bryant, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 342 F St, Chula Vista, CA 91910 Phone: 619-422-1471 Fax: 619-422-0114 | |
Emma Coleen Mcdonnell, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 | |
Maria E Castillejos, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 342 F St, Chula Vista, CA 91910 Phone: 619-422-1471 Fax: 619-422-0450 | |
Lina Amini, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3088 Fax: 619-397-3388 | |
Parnian Arjmand, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Dr. Tayson Delengocky, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 835 3rd Ave, Suite A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 |